Evidence map›Paper›PMID 32808114›Full record

ReviewJournal of physiology and biochemistry2020

Potential roles of bone morphogenetic protein-9 in glucose and lipid homeostasis.

Yichao Wang, Chenhui Ma, Tiantian Sun, Luping Ren

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of physiology and biochemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. The Influence of BMP6 on Serotonin and Glucose Metabolism.International journal of molecular sciences · 2024
    Article
  10. Article
  11. Metabolic Health and Disease: A Role of Osteokines?Calcified tissue international · 2023
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Yichao WangDepartment of Endocrinology and Metabolism, Hebei General Hospital, Shijiazhuang, Hebei, China.
Chenhui MaNorth China University of Science and Technology, Tangshan, Hebei, China.
Tiantian SunDepartment of Endocrinology and Metabolism, Hebei General Hospital, Shijiazhuang, Hebei, China.
Luping RenDepartment of Endocrinology and Metabolism, Hebei General Hospital, Shijiazhuang, Hebei, China. renluping1122@163.com.ORCID http://orcid.org/0000-0003-3662-8847
North China University of Science and Technology · CNHebei General Hospital · CN

Funding

Natural Science Foundation of Hebei Province H2019307114
6 · The paper itself

Abstract

Bone morphogenetic protein-9 (BMP-9) is a novel cytokine which is cloned from the fetal mouse liver cDNA library and belongs to the member of the transforming growth factor-β (TGF-β) superfamily. BMP-9 is mainly secreted by the liver and exerts a variety of physiological functions. In this review, we present the latest knowledge on the biochemistry of BMP-9 and its role in glucose metabolism and lipid homeostasis. We introduced the expression site, structure, synthesis, and secretion of BMP-9, as well as BMP-9 signaling pathway. We also discuss the effects of BMP-9 on glucose metabolism and lipid metabolism in different organs. BMP-9 can regulate glucose and lipid homeostasis in the body by inhibiting liver gluconeogenesis, transforming white adipose tissue to brown adipose tissue, promoting muscle glycogen synthesis, increasing the uptake and utilization of glucose by muscle tissue, increasing liver and adipose tissue insulin sensitivity, promoting insulin synthesis and secretion, inhibiting liver lipid deposition, and playing a leptin-like role. Finally, through the results of animal intervention studies and human clinical studies in the review, we deeply understand the association of BMP-9 with obesity, insulin resistance (IR), type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD), which provides new ideas for the prevention and treatment of diseases.

Indexed as

Insulin ResistanceLipid MetabolismAnimalsDiabetes Mellitus, Type 2GlucoseGrowth Differentiation Factor 2HumansNon-alcoholic Fatty Liver DiseaseObesityGDF2 protein, humanGlucoseGrowth Differentiation Factor 2BMP-9DiabetesGlucose metabolismLipid metabolismNAFLDObesity

Identifiers

PMID32808114
OpenAlexW3056613688

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.